Composition
- Active ingredients
- METFORMIN HYDROCHLORIDE 50MG/500MG; SITAGLIPTIN PHOSPHATE 50MG/1000MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA208535.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Metformin Hydrochloride and Sitagliptin Phosphate
- Active substance
- metformin hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Zydus Pharms USA Inc
- Status
- Tentative approval
- FDA approval
- 3 Jul 2017
- Application
- ANDA208535-001